

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | viral transcription (GO:0019083) | 7.62680171 |
| 2 | ribosomal small subunit biogenesis (GO:0042274) | 7.55259974 |
| 3 | cellular glucuronidation (GO:0052695) | 7.53421254 |
| 4 | translational termination (GO:0006415) | 7.30407388 |
| 5 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 7.29344655 |
| 6 | uronic acid metabolic process (GO:0006063) | 7.02755607 |
| 7 | glucuronate metabolic process (GO:0019585) | 7.02755607 |
| 8 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 6.70332621 |
| 9 | cotranslational protein targeting to membrane (GO:0006613) | 6.66271269 |
| 10 | protein targeting to ER (GO:0045047) | 6.59854126 |
| 11 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 6.37709029 |
| 12 | protein localization to endoplasmic reticulum (GO:0070972) | 6.27330938 |
| 13 | ribosomal large subunit biogenesis (GO:0042273) | 6.06729864 |
| 14 | translational elongation (GO:0006414) | 6.06348509 |
| 15 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.01253533 |
| 16 | ATP synthesis coupled proton transport (GO:0015986) | 6.01253533 |
| 17 | viral life cycle (GO:0019058) | 5.75054780 |
| 18 | cellular protein complex disassembly (GO:0043624) | 5.67949524 |
| 19 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.60966768 |
| 20 | retinal ganglion cell axon guidance (GO:0031290) | 5.34727548 |
| 21 | translational initiation (GO:0006413) | 5.31520064 |
| 22 | polyketide metabolic process (GO:0030638) | 5.29304273 |
| 23 | doxorubicin metabolic process (GO:0044598) | 5.29304273 |
| 24 | daunorubicin metabolic process (GO:0044597) | 5.29304273 |
| 25 | retinoic acid metabolic process (GO:0042573) | 5.28046147 |
| 26 | cranial nerve development (GO:0021545) | 4.99179797 |
| 27 | protein complex disassembly (GO:0043241) | 4.83035956 |
| 28 | macromolecular complex disassembly (GO:0032984) | 4.70594289 |
| 29 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.69263609 |
| 30 | translation (GO:0006412) | 4.65971051 |
| 31 | protein targeting to membrane (GO:0006612) | 4.58864186 |
| 32 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.57420056 |
| 33 | negative regulation of fatty acid metabolic process (GO:0045922) | 4.49665557 |
| 34 | RNA-dependent DNA replication (GO:0006278) | 4.15978443 |
| 35 | regulation of spindle organization (GO:0090224) | 3.98179644 |
| 36 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.97849703 |
| 37 | cellular component biogenesis (GO:0044085) | 3.88811939 |
| 38 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.86039343 |
| 39 | respiratory electron transport chain (GO:0022904) | 3.85283760 |
| 40 | chaperone-mediated protein transport (GO:0072321) | 3.80070559 |
| 41 | mRNA catabolic process (GO:0006402) | 3.79460853 |
| 42 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.77801192 |
| 43 | negative regulation of steroid metabolic process (GO:0045939) | 3.77251472 |
| 44 | electron transport chain (GO:0022900) | 3.75050942 |
| 45 | ribosomal small subunit assembly (GO:0000028) | 3.74431937 |
| 46 | mitotic chromosome condensation (GO:0007076) | 3.71825106 |
| 47 | transcription from mitochondrial promoter (GO:0006390) | 3.67398820 |
| 48 | protein neddylation (GO:0045116) | 3.61659400 |
| 49 | regulation of mitotic spindle organization (GO:0060236) | 3.59362094 |
| 50 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.53303215 |
| 51 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.51403595 |
| 52 | kinetochore organization (GO:0051383) | 3.48495280 |
| 53 | protein K6-linked ubiquitination (GO:0085020) | 3.46616981 |
| 54 | establishment of integrated proviral latency (GO:0075713) | 3.45923490 |
| 55 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.44722683 |
| 56 | RNA catabolic process (GO:0006401) | 3.42888466 |
| 57 | DNA strand elongation (GO:0022616) | 3.41931885 |
| 58 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.41147257 |
| 59 | DNA replication checkpoint (GO:0000076) | 3.39921090 |
| 60 | telomere maintenance via telomerase (GO:0007004) | 3.39322363 |
| 61 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.38083218 |
| 62 | ATP biosynthetic process (GO:0006754) | 3.37758537 |
| 63 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.37023100 |
| 64 | phenol-containing compound catabolic process (GO:0019336) | 3.35112512 |
| 65 | telomere maintenance via recombination (GO:0000722) | 3.33295583 |
| 66 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.30373565 |
| 67 | rRNA modification (GO:0000154) | 3.28834305 |
| 68 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.28070421 |
| 69 | parturition (GO:0007567) | 3.27720880 |
| 70 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.27341818 |
| 71 | resolution of meiotic recombination intermediates (GO:0000712) | 3.24363425 |
| 72 | mitotic metaphase plate congression (GO:0007080) | 3.24233473 |
| 73 | proteasome assembly (GO:0043248) | 3.23915374 |
| 74 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.21563545 |
| 75 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.21001114 |
| 76 | nucleobase biosynthetic process (GO:0046112) | 3.18946750 |
| 77 | establishment of protein localization to membrane (GO:0090150) | 3.18459883 |
| 78 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.15940408 |
| 79 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.15156647 |
| 80 | negative regulation of ligase activity (GO:0051352) | 3.15156647 |
| 81 | nucleoside salvage (GO:0043174) | 3.11370775 |
| 82 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 3.10582918 |
| 83 | regulation of mitochondrial translation (GO:0070129) | 3.09866828 |
| 84 | mitotic recombination (GO:0006312) | 3.08956865 |
| 85 | ribonucleoprotein complex disassembly (GO:0032988) | 3.07608443 |
| 86 | protein targeting (GO:0006605) | 3.07063685 |
| 87 | rRNA processing (GO:0006364) | 3.04707350 |
| 88 | positive regulation of ligase activity (GO:0051351) | 3.04388128 |
| 89 | maturation of SSU-rRNA (GO:0030490) | 3.02688946 |
| 90 | ribosome biogenesis (GO:0042254) | 3.01959384 |
| 91 | formation of translation preinitiation complex (GO:0001731) | 3.00181441 |
| 92 | quinone metabolic process (GO:1901661) | 2.99634902 |
| 93 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 2.99595313 |
| 94 | nerve development (GO:0021675) | 2.97924348 |
| 95 | purine nucleobase biosynthetic process (GO:0009113) | 2.97589769 |
| 96 | CENP-A containing nucleosome assembly (GO:0034080) | 2.97281508 |
| 97 | purine nucleotide salvage (GO:0032261) | 2.93028975 |
| 98 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.92321768 |
| 99 | flavonoid metabolic process (GO:0009812) | 11.5428698 |
| 100 | phenylpropanoid metabolic process (GO:0009698) | 11.1181005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.49258732 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.90904393 |
| 3 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.39221172 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.98369075 |
| 5 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.76631029 |
| 6 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.74633846 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.72352387 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.42579226 |
| 9 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.40665082 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.39665321 |
| 11 | ELK1_19687146_ChIP-ChIP_HELA_Human | 3.36927989 |
| 12 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.33896771 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.18365595 |
| 14 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.15008858 |
| 15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.09005274 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.06404373 |
| 17 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.92223902 |
| 18 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.89559181 |
| 19 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.67059416 |
| 20 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.60595871 |
| 21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.58718323 |
| 22 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.58504660 |
| 23 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.46088710 |
| 24 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.42980072 |
| 25 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.40805489 |
| 26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.33202179 |
| 27 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.32590462 |
| 28 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.29482674 |
| 29 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.16049387 |
| 30 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.12580454 |
| 31 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.10965317 |
| 32 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.08784177 |
| 33 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.08105665 |
| 34 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05678221 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.03634580 |
| 36 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.00981127 |
| 37 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.99888294 |
| 38 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.99019345 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.98784748 |
| 40 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.94718368 |
| 41 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.89696083 |
| 42 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.86240945 |
| 43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.82904576 |
| 44 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81220969 |
| 45 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.76871309 |
| 46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.71514314 |
| 47 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.67503537 |
| 48 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.61717451 |
| 49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61614966 |
| 50 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.57926189 |
| 51 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.56580942 |
| 52 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.55134390 |
| 53 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.50813318 |
| 54 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.50135841 |
| 55 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.48349353 |
| 56 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48089930 |
| 57 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.44858374 |
| 58 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.43616986 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.39177964 |
| 60 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.33490428 |
| 61 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.32924402 |
| 62 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.29108121 |
| 63 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.28296868 |
| 64 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.28058234 |
| 65 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.23397821 |
| 66 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.22588311 |
| 67 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15306541 |
| 68 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.13909815 |
| 69 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.11396009 |
| 70 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.10300114 |
| 71 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.09578738 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08874835 |
| 73 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07070687 |
| 74 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06523991 |
| 75 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.05390948 |
| 76 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.03517114 |
| 77 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.03447525 |
| 78 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.00374641 |
| 79 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97598875 |
| 80 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.96951300 |
| 81 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.96599622 |
| 82 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.96280344 |
| 83 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.92158673 |
| 84 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89395753 |
| 85 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.86984350 |
| 86 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.86451230 |
| 87 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.82634559 |
| 88 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.80529145 |
| 89 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.80056805 |
| 90 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.79162215 |
| 91 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.78973656 |
| 92 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.78386112 |
| 93 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.76676561 |
| 94 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75981626 |
| 95 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.73598836 |
| 96 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.72533790 |
| 97 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.72306638 |
| 98 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.71136767 |
| 99 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.71136767 |
| 100 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.70723781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 8.78202090 |
| 2 | MP0002938_white_spotting | 7.08102082 |
| 3 | MP0003077_abnormal_cell_cycle | 3.44137450 |
| 4 | MP0008007_abnormal_cellular_replicative | 2.96033400 |
| 5 | MP0009697_abnormal_copulation | 2.71347903 |
| 6 | MP0004957_abnormal_blastocyst_morpholog | 2.56578422 |
| 7 | MP0003186_abnormal_redox_activity | 2.55898295 |
| 8 | MP0003693_abnormal_embryo_hatching | 2.49942608 |
| 9 | MP0008058_abnormal_DNA_repair | 2.43193725 |
| 10 | MP0010094_abnormal_chromosome_stability | 2.19055551 |
| 11 | MP0003111_abnormal_nucleus_morphology | 2.16921670 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.08492096 |
| 13 | MP0002638_abnormal_pupillary_reflex | 11.6828423 |
| 14 | MP0009379_abnormal_foot_pigmentation | 1.89546342 |
| 15 | MP0006036_abnormal_mitochondrial_physio | 1.87868294 |
| 16 | MP0003718_maternal_effect | 1.87615803 |
| 17 | MP0001853_heart_inflammation | 1.62972490 |
| 18 | MP0003941_abnormal_skin_development | 1.60792521 |
| 19 | MP0005408_hypopigmentation | 1.52694245 |
| 20 | MP0001697_abnormal_embryo_size | 1.32524449 |
| 21 | MP0008932_abnormal_embryonic_tissue | 1.30191961 |
| 22 | MP0001851_eye_inflammation | 1.28564602 |
| 23 | MP0006035_abnormal_mitochondrial_morpho | 1.25505606 |
| 24 | MP0003221_abnormal_cardiomyocyte_apopto | 1.22312306 |
| 25 | MP0008057_abnormal_DNA_replication | 1.21666899 |
| 26 | MP0005670_abnormal_white_adipose | 1.21268985 |
| 27 | MP0008877_abnormal_DNA_methylation | 1.14808787 |
| 28 | MP0000313_abnormal_cell_death | 1.08648871 |
| 29 | MP0002932_abnormal_joint_morphology | 1.05070631 |
| 30 | MP0000358_abnormal_cell_content/ | 0.99464893 |
| 31 | MP0002160_abnormal_reproductive_system | 0.98126737 |
| 32 | MP0000350_abnormal_cell_proliferation | 0.96297216 |
| 33 | MP0001764_abnormal_homeostasis | 0.95120346 |
| 34 | MP0002132_abnormal_respiratory_system | 0.95110405 |
| 35 | MP0000858_altered_metastatic_potential | 0.94886534 |
| 36 | MP0000678_abnormal_parathyroid_gland | 0.91579165 |
| 37 | MP0002396_abnormal_hematopoietic_system | 0.91549308 |
| 38 | MP0002080_prenatal_lethality | 0.89294527 |
| 39 | MP0001286_abnormal_eye_development | 0.87750356 |
| 40 | MP0005330_cardiomyopathy | 0.86856305 |
| 41 | MP0002111_abnormal_tail_morphology | 0.86117451 |
| 42 | MP0001730_embryonic_growth_arrest | 0.84046642 |
| 43 | MP0004147_increased_porphyrin_level | 0.81055076 |
| 44 | MP0001881_abnormal_mammary_gland | 0.73821838 |
| 45 | MP0005266_abnormal_metabolism | 0.70485751 |
| 46 | MP0002928_abnormal_bile_duct | 0.68617270 |
| 47 | MP0000372_irregular_coat_pigmentation | 0.68203429 |
| 48 | MP0005384_cellular_phenotype | 0.66949555 |
| 49 | MP0005332_abnormal_amino_acid | 0.66762399 |
| 50 | MP0005621_abnormal_cell_physiology | 0.66758138 |
| 51 | MP0009765_abnormal_xenobiotic_induced | 0.66506754 |
| 52 | MP0005501_abnormal_skin_physiology | 0.65331701 |
| 53 | MP0003786_premature_aging | 0.63442825 |
| 54 | MP0001661_extended_life_span | 0.63222013 |
| 55 | MP0005193_abnormal_anterior_eye | 0.62140451 |
| 56 | MP0005410_abnormal_fertilization | 0.61872381 |
| 57 | MP0001905_abnormal_dopamine_level | 0.61237109 |
| 58 | MP0002019_abnormal_tumor_incidence | 0.59530843 |
| 59 | MP0005395_other_phenotype | 0.58328379 |
| 60 | MP0010030_abnormal_orbit_morphology | 0.57625847 |
| 61 | MP0005319_abnormal_enzyme/_coenzyme | 0.56582645 |
| 62 | MP0001340_abnormal_eyelid_morphology | 0.53897447 |
| 63 | MP0009780_abnormal_chondrocyte_physiolo | 0.52045411 |
| 64 | MP0005389_reproductive_system_phenotype | 0.52033642 |
| 65 | MP0002095_abnormal_skin_pigmentation | 0.51882926 |
| 66 | MP0001929_abnormal_gametogenesis | 0.50587238 |
| 67 | MP0005380_embryogenesis_phenotype | 0.50346560 |
| 68 | MP0001672_abnormal_embryogenesis/_devel | 0.50346560 |
| 69 | MP0004019_abnormal_vitamin_homeostasis | 0.49263484 |
| 70 | MP0005646_abnormal_pituitary_gland | 0.48896057 |
| 71 | MP0002210_abnormal_sex_determination | 0.46768607 |
| 72 | MP0003984_embryonic_growth_retardation | 0.46387558 |
| 73 | MP0002088_abnormal_embryonic_growth/wei | 0.45808820 |
| 74 | MP0008995_early_reproductive_senescence | 0.44746396 |
| 75 | MP0001216_abnormal_epidermal_layer | 0.43549254 |
| 76 | MP0002109_abnormal_limb_morphology | 0.41857767 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 0.41628176 |
| 78 | MP0002796_impaired_skin_barrier | 0.41435775 |
| 79 | MP0005376_homeostasis/metabolism_phenot | 0.41410515 |
| 80 | MP0005076_abnormal_cell_differentiation | 0.40379823 |
| 81 | MP0002085_abnormal_embryonic_tissue | 0.40071341 |
| 82 | MP0005636_abnormal_mineral_homeostasis | 0.38916055 |
| 83 | MP0002086_abnormal_extraembryonic_tissu | 0.38224802 |
| 84 | MP0000627_abnormal_mammary_gland | 0.37839820 |
| 85 | MP0001529_abnormal_vocalization | 0.36477812 |
| 86 | MP0002295_abnormal_pulmonary_circulatio | 0.36295760 |
| 87 | MP0001145_abnormal_male_reproductive | 0.36295317 |
| 88 | MP0000653_abnormal_sex_gland | 0.36134711 |
| 89 | MP0002114_abnormal_axial_skeleton | 0.35988670 |
| 90 | MP0003252_abnormal_bile_duct | 0.35685933 |
| 91 | MP0005195_abnormal_posterior_eye | 0.34458832 |
| 92 | MP0003638_abnormal_response/metabolism_ | 0.32927842 |
| 93 | MP0001186_pigmentation_phenotype | 0.32773366 |
| 94 | MP0000371_diluted_coat_color | 0.32033108 |
| 95 | MP0002098_abnormal_vibrissa_morphology | 0.31222648 |
| 96 | MP0000367_abnormal_coat/_hair | 0.31039629 |
| 97 | MP0004145_abnormal_muscle_electrophysio | 0.30867653 |
| 98 | MP0000377_abnormal_hair_follicle | 0.30374577 |
| 99 | MP0008873_increased_physiological_sensi | 0.30328423 |
| 100 | MP0004134_abnormal_chest_morphology | 0.30032389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 6.63997614 |
| 2 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 6.63997614 |
| 3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.35606038 |
| 4 | Stenosis of the external auditory canal (HP:0000402) | 6.13685946 |
| 5 | 3-Methylglutaconic aciduria (HP:0003535) | 6.06774305 |
| 6 | Macrocytic anemia (HP:0001972) | 5.65252098 |
| 7 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.77861723 |
| 8 | Acute necrotizing encephalopathy (HP:0006965) | 4.59081571 |
| 9 | Increased hepatocellular lipid droplets (HP:0006565) | 4.45969836 |
| 10 | Pallor (HP:0000980) | 4.35492574 |
| 11 | Renal Fanconi syndrome (HP:0001994) | 4.19354711 |
| 12 | Type I transferrin isoform profile (HP:0003642) | 4.14957637 |
| 13 | Acute encephalopathy (HP:0006846) | 4.02693343 |
| 14 | Lipid accumulation in hepatocytes (HP:0006561) | 3.91926944 |
| 15 | Mitochondrial inheritance (HP:0001427) | 3.86325773 |
| 16 | Increased intramyocellular lipid droplets (HP:0012240) | 3.85870645 |
| 17 | Progressive macrocephaly (HP:0004481) | 3.77250693 |
| 18 | Hypoplastic pelvis (HP:0008839) | 3.66264029 |
| 19 | Testicular atrophy (HP:0000029) | 3.63861037 |
| 20 | Increased CSF lactate (HP:0002490) | 3.52968737 |
| 21 | Abnormal number of erythroid precursors (HP:0012131) | 3.47661716 |
| 22 | Reduced antithrombin III activity (HP:0001976) | 3.42304374 |
| 23 | Hyperthyroidism (HP:0000836) | 3.41716247 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.37797545 |
| 25 | Generalized aminoaciduria (HP:0002909) | 3.28692954 |
| 26 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.19306881 |
| 27 | Increased muscle lipid content (HP:0009058) | 3.18310382 |
| 28 | Cerebral edema (HP:0002181) | 3.12849875 |
| 29 | Reticulocytopenia (HP:0001896) | 2.99413346 |
| 30 | Prolonged partial thromboplastin time (HP:0003645) | 2.98782773 |
| 31 | Homocystinuria (HP:0002156) | 2.93174472 |
| 32 | Abnormality of homocysteine metabolism (HP:0010919) | 2.93174472 |
| 33 | Exertional dyspnea (HP:0002875) | 2.91685693 |
| 34 | Abnormality of renal resorption (HP:0011038) | 2.88416019 |
| 35 | Absent thumb (HP:0009777) | 2.87993468 |
| 36 | Hepatic necrosis (HP:0002605) | 2.86344493 |
| 37 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.80690029 |
| 38 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.80690029 |
| 39 | Abnormal protein glycosylation (HP:0012346) | 2.80690029 |
| 40 | Abnormal glycosylation (HP:0012345) | 2.80690029 |
| 41 | Palpitations (HP:0001962) | 2.79704899 |
| 42 | Megaloblastic anemia (HP:0001889) | 2.78703150 |
| 43 | Neuroendocrine neoplasm (HP:0100634) | 2.72609109 |
| 44 | Decreased subcutaneous fat (HP:0001002) | 2.65124385 |
| 45 | Conjunctival hamartoma (HP:0100780) | 2.61316835 |
| 46 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.59314535 |
| 47 | Respiratory difficulties (HP:0002880) | 2.54587578 |
| 48 | Methylmalonic acidemia (HP:0002912) | 2.53342872 |
| 49 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.52807368 |
| 50 | Hypoparathyroidism (HP:0000829) | 2.50274573 |
| 51 | Hypertensive crisis (HP:0100735) | 2.48155053 |
| 52 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.47726042 |
| 53 | Lactic acidosis (HP:0003128) | 2.47104533 |
| 54 | Aplastic anemia (HP:0001915) | 2.47001483 |
| 55 | Neoplasm of head and neck (HP:0012288) | 2.45376226 |
| 56 | Esophageal neoplasm (HP:0100751) | 2.45376226 |
| 57 | Exercise intolerance (HP:0003546) | 2.40895532 |
| 58 | Hypoplasia of the radius (HP:0002984) | 2.40141293 |
| 59 | Hepatocellular necrosis (HP:0001404) | 2.39925472 |
| 60 | Increased serum lactate (HP:0002151) | 2.38835549 |
| 61 | Abnormal hair whorl (HP:0010721) | 2.31353548 |
| 62 | Pheochromocytoma (HP:0002666) | 2.28478574 |
| 63 | Truncus arteriosus (HP:0001660) | 2.28271170 |
| 64 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.28194399 |
| 65 | Oral leukoplakia (HP:0002745) | 2.27003053 |
| 66 | Respiratory failure (HP:0002878) | 2.26258947 |
| 67 | Leukodystrophy (HP:0002415) | 2.26108152 |
| 68 | Seborrheic dermatitis (HP:0001051) | 2.25540646 |
| 69 | Abnormality of urine glucose concentration (HP:0011016) | 2.25509934 |
| 70 | Glycosuria (HP:0003076) | 2.25509934 |
| 71 | Congenital, generalized hypertrichosis (HP:0004540) | 2.16210838 |
| 72 | Poor speech (HP:0002465) | 2.16052125 |
| 73 | Small hand (HP:0200055) | 2.13013981 |
| 74 | Proximal tubulopathy (HP:0000114) | 2.10748620 |
| 75 | Lip pit (HP:0100267) | 2.07677317 |
| 76 | Tinnitus (HP:0000360) | 2.07370992 |
| 77 | Paralysis (HP:0003470) | 2.06025560 |
| 78 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.05507578 |
| 79 | Patchy hypopigmentation of hair (HP:0011365) | 2.04880477 |
| 80 | Gout (HP:0001997) | 2.04090220 |
| 81 | Abnormality of the tricuspid valve (HP:0001702) | 1.96162758 |
| 82 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.93136827 |
| 83 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.88643515 |
| 84 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.87082944 |
| 85 | Abnormality of serum amino acid levels (HP:0003112) | 1.86544162 |
| 86 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.85507582 |
| 87 | Abnormality of glycolysis (HP:0004366) | 1.85222436 |
| 88 | Abnormal hemoglobin (HP:0011902) | 1.84418552 |
| 89 | Posterior subcapsular cataract (HP:0007787) | 1.83674861 |
| 90 | Increased serum pyruvate (HP:0003542) | 1.83326512 |
| 91 | Pancytopenia (HP:0001876) | 1.81473786 |
| 92 | Meningioma (HP:0002858) | 1.78401931 |
| 93 | Lethargy (HP:0001254) | 1.76650236 |
| 94 | Median cleft lip (HP:0000161) | 1.76310954 |
| 95 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.74474154 |
| 96 | Chromsome breakage (HP:0040012) | 1.72303169 |
| 97 | Patent foramen ovale (HP:0001655) | 1.72008599 |
| 98 | Hyperphosphaturia (HP:0003109) | 1.71937119 |
| 99 | Rough bone trabeculation (HP:0100670) | 1.69970149 |
| 100 | Methylmalonic aciduria (HP:0012120) | 1.68786942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 5.04752061 |
| 2 | ARAF | 3.89965034 |
| 3 | CDC7 | 3.87044374 |
| 4 | MAP3K12 | 3.82325181 |
| 5 | EIF2AK1 | 3.79863488 |
| 6 | BRSK2 | 3.62947566 |
| 7 | PBK | 2.78463495 |
| 8 | BMPR1B | 2.77048963 |
| 9 | STK16 | 2.60187747 |
| 10 | PAK4 | 2.52485745 |
| 11 | NEK1 | 2.45916862 |
| 12 | SRPK1 | 2.44201410 |
| 13 | TTK | 2.38529263 |
| 14 | CLK1 | 2.29704782 |
| 15 | VRK2 | 2.26736883 |
| 16 | BRAF | 2.01143862 |
| 17 | PIM2 | 1.87724050 |
| 18 | RPS6KB2 | 1.85934963 |
| 19 | BUB1 | 1.85849116 |
| 20 | PLK4 | 1.81695452 |
| 21 | NME1 | 1.79454263 |
| 22 | MYLK | 1.75538979 |
| 23 | AURKB | 1.72499858 |
| 24 | BRSK1 | 1.62710371 |
| 25 | EIF2AK3 | 1.62202460 |
| 26 | WEE1 | 1.48149421 |
| 27 | AURKA | 1.47568086 |
| 28 | PLK1 | 1.37041962 |
| 29 | VRK1 | 1.33948691 |
| 30 | CDK9 | 1.26752912 |
| 31 | NUAK1 | 1.20077839 |
| 32 | RAF1 | 1.17254424 |
| 33 | NEK2 | 1.08433548 |
| 34 | STK4 | 1.06575235 |
| 35 | BCKDK | 1.06007526 |
| 36 | PLK3 | 1.02857186 |
| 37 | CSNK2A2 | 0.98699937 |
| 38 | TLK1 | 0.98112550 |
| 39 | ABL2 | 0.86864133 |
| 40 | PHKG2 | 0.84798987 |
| 41 | PHKG1 | 0.84798987 |
| 42 | EIF2AK2 | 0.84304909 |
| 43 | CHEK1 | 0.81101939 |
| 44 | MAP3K2 | 0.75618426 |
| 45 | MAP3K8 | 0.75274752 |
| 46 | CCNB1 | 0.71718202 |
| 47 | CSNK2A1 | 0.71370278 |
| 48 | PRKCI | 0.69469126 |
| 49 | ERBB4 | 0.68880076 |
| 50 | CSNK1E | 0.67060764 |
| 51 | ILK | 0.65088799 |
| 52 | CHEK2 | 0.64947699 |
| 53 | MARK3 | 0.62091295 |
| 54 | CDK7 | 0.61148864 |
| 55 | RIPK4 | 0.60498494 |
| 56 | AKT2 | 0.60418889 |
| 57 | RPS6KA5 | 0.60318826 |
| 58 | PAK2 | 0.59377817 |
| 59 | ZAK | 0.57793585 |
| 60 | YES1 | 0.57261656 |
| 61 | MST1R | 0.54308400 |
| 62 | ATR | 0.53501171 |
| 63 | PLK2 | 0.53451306 |
| 64 | BMPR2 | 0.53259612 |
| 65 | PAK1 | 0.51186774 |
| 66 | CDK1 | 0.50566056 |
| 67 | MAP3K3 | 0.49102800 |
| 68 | PTK2 | 0.48731766 |
| 69 | NME2 | 0.47162198 |
| 70 | ATM | 0.47121195 |
| 71 | STK10 | 0.43530797 |
| 72 | CDK2 | 0.42799630 |
| 73 | CDK8 | 0.42773947 |
| 74 | CSNK1G3 | 0.42245022 |
| 75 | PRKACB | 0.42195582 |
| 76 | TAOK3 | 0.40167340 |
| 77 | CSNK1D | 0.40082114 |
| 78 | CAMKK2 | 0.39710675 |
| 79 | RPS6KL1 | 0.39399206 |
| 80 | RPS6KC1 | 0.39399206 |
| 81 | PIM1 | 0.39204068 |
| 82 | PRKG2 | 0.36487674 |
| 83 | PDK2 | 0.36335297 |
| 84 | NEK9 | 0.36293184 |
| 85 | CSNK1A1L | 0.34329857 |
| 86 | RPS6KA6 | 0.33998246 |
| 87 | SGK1 | 0.31924417 |
| 88 | KSR2 | 0.30142760 |
| 89 | PTK6 | 0.29482767 |
| 90 | CSNK1G2 | 0.29063752 |
| 91 | DAPK3 | 0.28504682 |
| 92 | CAMK2G | 0.27411017 |
| 93 | PRKG1 | 0.26862635 |
| 94 | MINK1 | 0.26640169 |
| 95 | TNIK | 0.26623015 |
| 96 | CDK3 | 0.22309013 |
| 97 | STK3 | 0.20604838 |
| 98 | PASK | 0.20219458 |
| 99 | DAPK1 | 0.19407104 |
| 100 | CSNK1G1 | 0.17220938 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.49479534 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 4.88672189 |
| 3 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 4.56619324 |
| 4 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 3.84334616 |
| 5 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 3.63386728 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 3.31823250 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.25049130 |
| 8 | Mismatch repair_Homo sapiens_hsa03430 | 3.14963295 |
| 9 | Protein export_Homo sapiens_hsa03060 | 3.03930795 |
| 10 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.94707299 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.81155747 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 2.80308299 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.59769246 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.50675401 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.27691200 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16735361 |
| 17 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.12733638 |
| 18 | Retinol metabolism_Homo sapiens_hsa00830 | 2.09127801 |
| 19 | Homologous recombination_Homo sapiens_hsa03440 | 2.05360032 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.86287381 |
| 21 | Alzheimers disease_Homo sapiens_hsa05010 | 1.86045400 |
| 22 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.82886023 |
| 23 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.58621700 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.56783131 |
| 25 | Spliceosome_Homo sapiens_hsa03040 | 1.45758642 |
| 26 | Base excision repair_Homo sapiens_hsa03410 | 1.40927541 |
| 27 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.29697060 |
| 28 | RNA polymerase_Homo sapiens_hsa03020 | 1.26244958 |
| 29 | Basal transcription factors_Homo sapiens_hsa03022 | 1.16846627 |
| 30 | RNA transport_Homo sapiens_hsa03013 | 1.13815528 |
| 31 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.08712484 |
| 32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.04329773 |
| 33 | RNA degradation_Homo sapiens_hsa03018 | 0.95963761 |
| 34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.93975084 |
| 35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86729478 |
| 36 | Cell cycle_Homo sapiens_hsa04110 | 0.83865931 |
| 37 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77368239 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.74533704 |
| 39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70770180 |
| 40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69022792 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.56062819 |
| 42 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53649756 |
| 43 | Purine metabolism_Homo sapiens_hsa00230 | 0.51681712 |
| 44 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.51121465 |
| 45 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50916513 |
| 46 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50004503 |
| 47 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.47679016 |
| 48 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.43661545 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42231968 |
| 50 | Mineral absorption_Homo sapiens_hsa04978 | 0.41428984 |
| 51 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.41267766 |
| 52 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40867158 |
| 53 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.37690392 |
| 54 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37593102 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36031497 |
| 56 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33680227 |
| 57 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33611190 |
| 58 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32699275 |
| 59 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.31763989 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27495930 |
| 61 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.27484358 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 0.26485438 |
| 63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.25683292 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.25027059 |
| 65 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.24476868 |
| 66 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.23878264 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.23557053 |
| 68 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.22854849 |
| 69 | Circadian rhythm_Homo sapiens_hsa04710 | 0.19523280 |
| 70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.19031815 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.17079278 |
| 72 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.16512944 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.14961712 |
| 74 | Shigellosis_Homo sapiens_hsa05131 | 0.14500751 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.09732406 |
| 76 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.06833712 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.05795459 |
| 78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.04148899 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.03828769 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.03746253 |
| 81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.02036533 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.01925235 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | -0.1670700 |
| 84 | Pathways in cancer_Homo sapiens_hsa05200 | -0.1666240 |
| 85 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | -0.1644543 |
| 86 | Wnt signaling pathway_Homo sapiens_hsa04310 | -0.1620258 |
| 87 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.1589357 |
| 88 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | -0.1524617 |
| 89 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1371375 |
| 90 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1339920 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.1321755 |
| 92 | Alcoholism_Homo sapiens_hsa05034 | -0.1308545 |
| 93 | Butanoate metabolism_Homo sapiens_hsa00650 | -0.1299626 |
| 94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | -0.0904816 |
| 95 | Fatty acid elongation_Homo sapiens_hsa00062 | -0.0837643 |
| 96 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | -0.0832049 |
| 97 | Small cell lung cancer_Homo sapiens_hsa05222 | -0.0687607 |
| 98 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | -0.0455326 |
| 99 | p53 signaling pathway_Homo sapiens_hsa04115 | -0.0392123 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0011668 |

